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SUMMARY
Sleep and circadian rhythms are intrinsically linked, with several sleep
traits, including sleep timing and duration, inﬂuenced by both sleep
homeostasis and the circadian phase. Genetic variation in several
circadian genes has been associated with diurnal preference (preference
in timing of sleep), although there has been limited research on whether
they are associated with other sleep measurements. We investigated
whether these genetic variations were associated with diurnal preference
(Morningness–Eveningness Questionnaire) and various sleep measures,
including: the global Pittsburgh Sleep Quality index score; sleep duration;
and sleep latency and sleep quality. We genotyped 10 polymorphisms in
genes with circadian expression in participants from the G1219 sample
(n = 966), a British longitudinal population sample of young adults. We
conducted linear regressions using dominant, additive and recessive
models of inheritance to test for associations between these polymor-
phisms and the sleep measures. We found a signiﬁcant association
between diurnal preference and a polymorphism in period homologue 3
(PER3) (P < 0.005, recessive model) and a novel nominally signiﬁcant
association between diurnal preference and a polymorphism in aryl
hydrocarbon receptor nuclear translocator-like 2 (ARNTL2) (P < 0.05,
additive model). We found that a polymorphism in guanine nucleotide
binding protein beta 3 (GNb3) was associated signiﬁcantly with global
sleep quality (P < 0.005, recessive model), and that a rare polymorphism
in period homologue 2 (PER2) was associated signiﬁcantly with both
sleep duration and quality (P < 0.0005, recessive model). These ﬁndings
suggest that genes with circadian expression may play a role in regulating
both the circadian clock and sleep homeostasis, and highlight the
importance of further studies aimed at dissecting the speciﬁc roles that
circadian genes play in these two interrelated but unique behaviours.
INTRODUCTION
Circadian rhythms are daily cycles controlled by a central
hypothalamic pacemaker and affect a wide range of physi-
ological and behavioural, outputs including the sleep–wake
cycle (Franken and Dijk, 2009). This central pacemaker is
known to be governed by a complex molecular clock, which
consists of various transcriptional feedback loops and output
systems (reviewed in Zhang and Kay, 2010). Previous
research has determined a number of the genes involved in
these transcriptional feedback loops that drive the central
pacemaker (the clock genes) and numerous other genes
whose expression are rhythmically regulated by these core
clock genes (reviewed in Zhang and Kay, 2010).
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Diurnal preference, an individual’s preference of timing of
the sleep–wake cycle, is inﬂuenced by both the circadian clock
and by sleep homeostatis (Kerkhof, 1991; Mongrain et al.,
2004, 2006; Schmidt et al., 2009; Taillard et al., 2003). Diurnal
preference and certain sleep measures, including sleep
quality and duration, vary across individuals. Twin studies
suggest that genetic inﬂuences partially underlie the variation
seen for diurnal preference, sleep quality and sleep duration
(Barclay et al., 2010a,b; Partinen et al., 1983). Previously,
genetic variation in several clock genes [circadian locomotor
output cycles kaput (CLOCK), period homologue (PER)1,
PER2, PER3] has been shown to be associated with diurnal
preference in the general population (Archer et al., 2010;
Carpen et al., 2006; Katzenberg et al., 1998; Lee et al., 2007,
2011). Genetic variation in guanine nucleotide binding protein
beta 3 (GNb3), which has circadian expression in the mouse
pituitary (Hughes et al., 2009), has also been associated with
diurnal preference (Johansson et al., 2004). Similarly, other
studies have suggested that variation in other circadian
genes, aryl hydrocarbon receptor nuclear translocator-like 2
(ARNTL2) and D site of albumin promoter (albumin D-box)
binding protein (DBP), may affect speciﬁc circadian outputs,
such as daily changes in mood (Shi et al., 2008).
Sleep and circadian rhythms are intrinsically linked, with a
number of sleep traits, including sleep timing and duration,
inﬂuenced by both sleep homeostasis and the circadian
phase (Borbely, 1982). Given the inﬂuences of the circadian
clock on sleep behaviours, we hypothesized that the same
single nucleotide polymorphisms (SNPs) that had been
associated with diurnal preference could also be associated
with additional subjective sleep measures. We thus
attempted to both replicate the associations of these SNPs
in genes with circadian expressionwith diurnal preference
and to further investigate whether they were associated with
speciﬁc subjective sleep measures in the G1219 sample. We
limited our investigations to those SNPs that were associated
previously with diurnal preference and circadian outputs, e.g.
worse evening mood (summarized in Table 1), including a
rare, unpublished F-box and leucine-rich repeat protein 3
(FBXL3) SNP that was found previously to be associated with
extreme values of diurnal preference (S. N. Archer, unpub-
lished data).
MATERIALS AND METHODS
Participants
The participants in this study come from the G1219 and
G1219 Twins longitudinal studies (McAdams et al., 2013).
The G1219 sample comprises the adolescent offspring of
adults from a large-scale population-based study (Eley et al.,
2004), while the G1219 Twins sample comprises randomly
selected twin sets born between 1985 and 1988 (McAdams
et al., 2013). Informed consent was obtained from parents/
guardians of all adolescents aged <16 years, and from the
adolescents themselves when ≥16 years old. Ethical
approval for different stages of this study has been provided
by the Research Ethics Committees of the Institute of
Psychiatry, South London and Maudsley NHS Trust, and
Goldsmiths, University of London.
Table 1 Summary of Investigated single nucleotide polymorphisms (SNPs)
Gene SNP ID Allele
Genotypic frequency
Gene region Related phenotype CitationM/M M/m m/m
ARNTL2 rs922270 T/C 690 (72.9) 240 (25.3) 17 (1.8) Intronic region Worse evening
mood
Shi et al. (2008)
CLOCK rs2070062 T/C 530 (56.1) 341 (36.1) 73 (7.7) 30 UTR region Diurnal preference Pedrazzoli et al. (2007)
DBP rs3848543 C/T 673 (73.3) 231 (25.2) 14 (1.5) Intronic region Worse evening
mood
Shi et al. (2008)
FBXL3 825679097 G/T 939 (99.8) 2 (0.2) 0 (0) Coding (Gly/Val) Diurnal preference S. N. Archer (unpublished
data)
GNb3 rs5443 C/T 466 (49.4) 387 (41) 91 (9.6) Affects splicing Diurnal preference Johansson et al. (2004)
PER1 rs2735611 T/C 688 (73.7) 224 (24) 22 (2.4) Coding (silent) Diurnal preference Carpen et al. (2006)
PER2 rs934945 G/A 604 (64.2) 295 (31.4) 42 (4.5) Coding (Gly/Glu) Diurnal preference Lee et al. (2007) and
Carpen et al. (2006)
PER2 rs2304672 C/G 796 (84.4) 144 (15.3) 3 (0.3) Promoter region Diurnal preference Carpen et al. (2006) and
Lee et al. (2011)
PER3 rs2797687 G/T 611 (67.1) 266 (29.2) 33 (3.6) Promoter region DSPD Archer et al. (2010)
PER3 rs10462020 G/T 606 (64.3) 274 (29.1) 63 (6.7) Coding (Val/Gly) Diurnal preference
and DSPD
Johansson et al. (2003);
Ebisawa et al. (2001)
ARNTL2, aryl hydrocarbon receptor nuclear translocator-like 2; CLOCK, circadian locomotor output cycles kaput; DBP, D site of albumin
promoter (albumin D-box) binding protein; PER, period homologue (PER1, PER2, PER3); FBXL3, F-box and leucine-rich repeat protein 3;
GNb3, guanine nucleotide binding protein beta 3; DSPD, delayed sleep phase disorder.
The genotypic frequencies for the 10 SNPs that varied in the G1219 sample are listed in this table. The allele lists the major allele ﬁrst (M) and
minor allele second (m). The genotypic frequencies relate to the major and minor alleles. Additional information is listed for each SNP,
including its position relative to the gene and the related phenotype.
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This study focuses exclusively on wave 4, comprising 1556
individuals (collected in 2007) as, at the time of analyses,
subjective sleep data were available at this wave only.
Individuals were selected for inclusion if sleep measures
were available and DNA had been collected. The total
sample was 1130 (73% of those participating at wave 4). For
monozygotic (MZ) twin pairs, data from only one individual,
selected at random, was included in the analyses. The
analyses are based on sleep data and DNA from 952 wave
four participants [mean age = 20.3 years, standard deviation
(SD) = 1.77, age range 18–27 years; 61.0% female] con-
sisting of 562 dizygotic (DZ) individuals, 180 MZ individuals
and 210 individuals from sibling pairs.
Measures
Diurnal preference
The Morningness–Eveningness Questionnaire (MEQ, Horne
and Oostburg, 1976) measured diurnal preference. The
MEQ is a 19-item self-report questionnaire which assesses
individual preference for the timing of a number of diurnal
activities, sleeping habits, hours of peak performance and
times of ‘feeling best’ and maximum alertness. Individual
items are rated on a 4- or 5-point scale and the total score
ranges from 16 to 86. Higher scores indicate a greater
‘morningness’ preference. For further details of the validity
of the MEQ in the G1219 sample, see elsewhere (Barclay
et al., 2010a). The MEQ score had a mean of 48.6
(SD = 8.2).
Sleep quality
Sleep quality was assessed using the Pittsburgh Sleep
Quality Index (PSQI; Buysse et al., 1989), which is a widely
used questionnaire measure containing 18 items assessing
sleep over the previous month. Global scores range from 0 to
21, with higher scores indicating poorer sleep quality. For
further details of the validity of the MEQ in the G1219 sample,
see elsewhere (Barclay et al., 2011). The global PSQI mean
score was 5.9 (SD = 3.1).
In addition to the global score, three measures of sleep
(sleep duration, sleep latency and sleep quality) were
assessed using the PSQI. Sleep duration was measured
using question 4 of this questionnaire: ‘During the past
month, how many hours of actual sleep did you get at night?’.
Sleep duration ranged from 2 to 12 h with a mean of 7.5 h
(SD = 1.2). Sleep latency was measured using question 2 of
this questionnaire: ‘During the past month, how long (in min)
has it usually taken you to fall asleep each night?’. Sleep
latency ranged from 0 to 240 min and had a mean of 27.8
(SD = 23.3). Sleep quality was measured using question 6 of
this questionnaire: ‘During the past month, how would you
rate your sleep quality overall?’, and was scored: very
good = 0; fairly good = 1; fairly bad = 2; and very bad = 3.
Sleep quality had a mean score of 1.13 (SD = 0.71).
DNA extraction and genotyping
Cheek swab kits were posted to participants in order to collect
DNA, primarily during wave 4. The DNA extractions are
described elsewhere (Barclay et al., 2011). Ten single nucle-
otide polymorphisms (SNPs) were genotyped from a number
of genes with circadian expression (see Table 1). The
FBXL3_1362G/T SNP that was found previously to be asso-
ciated with extreme values of diurnal preference (S. N. Archer,
unpublished data) was submitted to dbSNP and has the SNP
submission number: 825679097. All the genotyping assays
were performed by KBioscience (http://www.lgcgenomics.
com/) using KASPar chemistry (for more details see: http://
www.lgcgenomics.com/genotyping/kasp-genotyping-reagents/
kasp-overview/). Blind duplicates and Hardy–Weinberg equi-
librium (HWE) tests were used as quality control tests. Linkage
disequilibrium and HWE were calculated using the Haploview
program (Barrett et al., 2005). The PER3 SNP rs10462020
failed to reach HWE in the total sample (v2 = 16.1,
P = 0.0001), but was in HWE in the male subset (P < 0.05).
All other SNPs were in HWE (P < 0.05).
Statistical analyses
All analyses were performed in STATA (StataCorp., 2002).
Linear regressions were conducted to model the main effect
of the SNPs on diurnal preference, global PSQI sleep quality,
sleep duration, sleep latency and sleep quality. Age and sex
were ﬁrst entered into the regression models, followed by
main effects of genotype. We investigated the three non-
independent models of inheritance: additive, dominant and
recessive (Lewis and Knight, 2012). To investigate the
combined effects of SNPs on speciﬁc sleep measures, we
also conducted regression analyses for each sleep pheno-
type adding all 10 of the SNPs we investigated into the model
simultaneously. So that we could determine additionally if the
signiﬁcant individual associations were independent of each
other, we varied the model of inheritance included in the
combined analysis for each measure investigated. For each
measure we included the model of inheritance that was most
signiﬁcant for each SNP from the individual analysis; for
those SNPs with no signiﬁcant model of inheritance for that
measure we used the additive model of inheritance. As our
sample included related individuals, all analyses were
corrected conservatively for the non-independence of the
twin/sibling observations using the ‘robust’ cluster command
in STATA, as is standard in analyses of this type (see Rogers,
1993). This analysis should correct for any failures to reach
the assumptions that are required for using linear models,
such as linearity, independence, normality and homoscedas-
ticity. If these assumptions are met, then a standard linear
regression model should account for differences in group size
across the genotype groups. We applied a Bonferroni
correction to control for multiple testing independently for
each of the sleep measures. We adjusted the P-value by
using the total number of SNPs investigated for each trait,
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thus the corrected P-values for diurnal preference, global
PSQI sleep quality, sleep duration, sleep latency and sleep
quality are: corrected P = 0.05/10 = 0.005. We did not apply
corrections for multiple testing for the number of inheritance
models that we ran, as these tests were not independent of
each other, and instead tested related hypotheses. Similarly,
we did not apply further multiple testing corrections across all
the phenotypes investigated, as a number of sleep measures
are at least partially correlated and thus are not fully
independent tests. If we were to correct stringently for all
sleep measures investigated, then we would require a
Bonferroni-adjusted P-value of 0.001. None of the analyses
reported here would survive this correction, but this would be
a very conservative correction given that the sleep measures
are not completely independent of each other.
RESULTS
The genotype counts and percentages for the 10 SNPs
investigated are summarized in Table 1. Table 2 summa-
rizes the means and standard deviations for each measure
by genotype.
Table 2 Means and standard deviations for all sleep measures by genotype
Gene SNP ID Allele Diurnal preference Global PSQI Sleep duration Sleep latency Sleep quality
ARNTL2 rs922270 TT 48.4 (8.2) 5.9 (3.2) 7.5 (1.2) 28.7 (23.2) 1.2 (0.7)
TC 48.8 (8.2) 5.6 (2.9) 7.5 (1.1) 26.1 (24.3) 1 (0.7)
CC 52.6 (6.6) 6 (2.6) 7.6 (0.9) 20.7 (13.3) 1.1 (0.6)
Total n 945 927 932 934 941
CLOCK rs2070062 TT 48.6 (8.2) 5.8 (3.2) 7.5 (1.2) 28.3 (24.6) 1.1 (0.7)
TG 48.7 (8.1) 5.9 (2.9) 7.4 (1.2) 26.9 (21.2) 1.1 (0.7)
GG 47.7 (9.1) 5.8 (3.1) 7.4 (1.2) 25.7 (16.3) 1.2 (0.7)
Total n 942 924 929 931 938
DBP rs3848543 CC 48.7 (8.3) 5.9 (3.1) 7.4 (1.2) 28.8 (24.9) 1.1 (0.7)
CT 48.4 (7.8) 5.5 (3.2) 7.6 (1.2) 24.9 (18.2) 1.1 (0.7)
TT 46.2 (9.4) 6.3 (4) 6.9 (1.3) 28.9 (25.7) 1.2 (0.8)
Total n 916 899 903 905 913
FBXL3 825679097 GG 48.5 (8.2) 5.9 (3.1) 7.5 (1.2) 27.8 (23.5) 1.1 (0.7)
GT 52 (11.3) 5 (1.4) 8.3 (1.1) 22.5 (10.6) 1 (0.0)
Total n 938 920 925 927 934
GNb3 rs5443 CC 48.3 (8.2) 5.9 (3) 7.5 (1.2) 27.3 (20.3) 1.2 (0.7)
CT 48.6 (8.5) 6 (3.3) 7.4 (1.3) 28.6 (27) 1.1 (0.8)
TT 49.5 (7.4) 5.1 (2.8) 7.7 (1) 26.8 (21.5) 1 (0.7)
Total n 942 924 929 931 938
PER1 rs2735611 TT 48.7 (8.3) 5.9 (3.1) 7.5 (1.2) 28 (23.9) 1.1 (0.7)
TC 48.2 (8) 5.8 (3) 7.6 (1.2) 27.2 (21.9) 1.2 (0.7)
CC 48.8 (6.4) 6.3 (3.8) 7 (1.1) 31.7 (28.2) 1 (0.7)
Total n 932 914 919 921 928
PER2 rs934945 GG 48.6 (8.4) 5.8 (3.1) 7.5 (1.2) 27.6 (24.1) 1.1 (0.7)
GA 48.6 (7.9) 6.1 (3.1) 7.4 (1.2) 29.1 (22.9) 1.2 (0.7)
AA 49.8 (9.2) 6.1 (3.4) 7.3 (1.1) 24.9 (15.9) 1.2 (0.8)
Total n 939 922 927 928 935
PER2 rs2304672 CC 48.7 (8.1) 5.8 (3.1) 7.5 (1.2) 27 (21.2) 1.1 (0.7)
CG 48 (8.7) 6 (3.3) 7.5 (1.4) 31.5 (30.2) 1.1 (0.7)
GG 42.3 (7.5) 4.3 (1.5) 8.2 (0.3) 21.7 (7.6) 1 (0)
Total n 941 923 928 930 937
PER3 rs2797687 CC 48.4 (8.5) 5.9 (3.1) 7.5 (1.2) 28.1 (23.2) 1.1 (0.7)
CA 48.6 (7.6) 5.8 (3.1) 7.5 (1.3) 27.4 (22.6) 1.2 (0.7)
AA 49.4 (8.4) 5.8 (2.8) 7.3 (1) 26.1 (23.8) 1.1 (0.6)
Total n 908 891 895 898 905
PER3 rs10462020 TT 48.2 (8.3) 5.9 (3.1) 7.4 (1.2) 28.1 (22.9) 1.1 (0.7)
TG 48.5 (8) 6 (3.2) 7.6 (1.3) 27.2 (21.1) 1.2 (0.7)
GG 51.3 (7.7) 5.3 (2.7) 7.6 (1.2) 29.7 (34.9) 1 (0.6)
Total n 941 923 928 930 937
ARNTL2, aryl hydrocarbon receptor nuclear translocator-like 2; CLOCK, circadian locomotor output cycles kaput; DBP, D site of albumin
promoter (albumin D-box) binding protein; PSQI, Pittsburgh Sleep Quality Index; PER, period homologue (PER1, PER2, PER3); FBXL3, F-
box and leucine-rich repeat protein 3; GNb3, guanine nucleotide binding protein beta 3.
The mean scores with standard deviations (in parentheses) are listed for all sleep measures by genotype, including: diurnal preference (range
of 16–86, a higher score indicates greater preference for morningness), global PSQI score (range from 0 to 21, with higher scores indicating
poorer overall sleep quality); sleep duration (h), sleep latency (min) and sleep quality (range 0–3, higher scores indicate poorer sleep quality).
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Diurnal preference
There was a signiﬁcant association between the PER3
SNP rs10462020 genotype and the mean diurnal prefer-
ence score using a recessive model of inheritance
(P = 0.003) (see Table 3 for a summary of the linear
regression scores). These results indicate that the GG
individuals (n = 63) had a higher diurnal preference score,
and thus an increased morning preference (mean = 51.3,
SD = 7.7), than the TT and TG individuals (mean = 48.3,
SD = 8.2) (see Fig. 1a). There was also a nominally
signiﬁcant association between this SNP and mean diurnal
preference using an additive model, P = 0.02). As this SNP
was not in HWE in the total sample, but was in HWE in the
male subsample, we repeated the regression analyses in
the male subsample. We found that there was still a
signiﬁcant association between rs10462020 genotype and
the mean diurnal preference in the male subsample using
a recessive model of inheritance (b = 5.2, P = 0.003).
There was also a nominally signiﬁcant association
between the ARNTL2 SNP rs922270 and mean diurnal
preference score using a recessive model (P = 0.02) (see
Fig. 1b). These results indicate that the CC individuals
(n = 17) had a higher diurnal preference, and thus an
increased morning preference (mean = 52.6, SD = 6.6),
than the TT and TC individuals (mean = 48.5, SD = 8.2).
In the combined analysis (including all 10 SNPs investigated),
the PER3 SNP remained signiﬁcant (b = 3.3, P = 0.003,
recessive model), although the ARNTL2 SNP did not
(b = 2.8, P = 0.013, recessive model). We also found two
novel associations not seen in the individual analysis: the rare
FBXL3SNP825679097 (b = 11.7,P < 0.0001, additivemodel)
and theGNb3 SNP rs5443 (b = 0.9, P = 0.04, additive model).
Global PSQI score
There was a signiﬁcant association between the GNb3 SNP
rs5443 and the global PSQI score using a recessive model
Table 3 Standardized regression coefﬁcients b (SE) from linear regression analyses for main effects of genotype on all sleep measures
Gene SNP Diurnal reference Global PSQI Sleep duration Sleep latency Sleep quality
ARNTL2 rs922270 Additive 0.76 (0.53) 0.23 (0.2) 0.02 (0.08) 2.96 (1.47)* 0.1 (0.05)*
Recessive 3.72 (1.55)* 0.07 (0.56) 0.06 (0.21) 7.19 (3.11)* 0.02 (0.14)
Dominant 0.59 (0.59) 0.28 (0.23) 0.02 (0.09) 2.97 (1.76) 0.12 (0.05)*
CLOCK rs2070062 Additive 0.27 (0.44) 0.02 (0.17) 0.08 (0.06) 1.37 (1.09) 0.03 (0.04)
Recessive 0.74 (1.11) 0.05 (0.4) 0.1 (0.16) 2.42 (2.16) 0.06 (0.09)
Dominant 0.23 (0.53) 0.02 (0.21) 0.1 (0.08) 1.55 (1.49) 0.04 (0.05)
DBP rs3848543 Additive 0.54 (0.56) 0.31 (0.23) 0.03 (0.09) 2.99 (1.51)* 0.06 (0.05)
Recessive 2.58 (2.33) 0.44 (0.94) 0.63 (0.33) 1.02 (6.65) 0.09 (0.2)
Dominant 0.45 (0.6) 0.41 (0.25) 0.09 (0.09) 3.65 (1.59)* 0.08 (0.06)
FBXL3 825679097 Additive 2.33 (5.88) 1.1 (0.82) 0.81 (0.44) 4.76 (5.03) 0.15 (0.04)**
Dominant 2.33 (5.88) 1.1 (0.82) 0.81 (0.44) 4.76 (5.03) 0.15 (0.04)**
GNb3 rs5443 Additive 0.53 (0.4) 0.23 (0.15) 0.04 (0.06) 0.35 (1.11) 0.07 (0.03)*
Recessive 0.95 (0.81) 0.9 (0.32)** 0.24 (0.11)* 1.03 (2.34) 0.2 (0.08)*
Dominant 0.59 (0.56) 0.09 (0.21) 0 (0.08) 0.96 (1.6) 0.06 (0.05)
PER1 rs2735611 Additive 0.28 (0.49) 0 (0.22) 0.01 (0.08) 0.08 (1.58) 0.02 (0.05)
Recessive 0.13 (1.38) 0.38 (0.88) 0.49 (0.27) 3.96 (6.2) 0.14 (0.17)
Dominant 0.34 (0.58) 0.04 (0.23) 0.06 (0.09) 0.51 (1.69) 0.03 (0.05)
PER2 rs934945 Additive 0.29 (0.47) 0.28 (0.19) 0.13 (0.07) 0.24 (1.24) 0.04 (0.04)
Recessive 1.43 (1.34) 0.31 (0.57) 0.21 (0.17) 3.32 (2.64) 0.09 (0.13)
Dominant 0.15 (0.56) 0.34 (0.22) 0.14 (0.08) 0.96 (1.61) 0.05 (0.05)
PER2 rs2304672 Additive 1.16 (0.75) 0.04 (0.28) 0.01 (0.11) 3.93 (2.44) 0.04 (0.06)
Recessive 5.66 (3.68) 1.47 (0.79) 0.78 (0.15)** 6.04 (4) 0.12 (0.03)**
Dominant 1.1 (0.78) 0.08 (0.3) 0.01 (0.12) 4.34 (2.58) 0.04 (0.06)
PER3 rs2797687 Additive 0.32 (0.48) 0.06 (0.18) 0.01 (0.07) 0.85 (1.37) 0.01 (0.04)
Recessive 0.81 (1.38) 0.09 (0.49) 0.25 (0.17) 1.95 (4.23) 0.04 (0.11)
Dominant 0.32 (0.56) 0.06 (0.22) 0.02 (0.09) 0.87 (1.59) 0.02 (0.05)
PER3 rs10462020 Additive 1.02 (0.43)* 0.09 (0.16) 0.11 (0.06) 0.02 (1.52) 0.01 (0.04)
Recessive 2.99 (1.01)** 0.6 (0.35) 0.14 (0.15) 1.85 (4.41) 0.11 (0.08)
Dominant 0.87 (0.55) 0.01 (0.21) 0.14 (0.08) 0.47 (1.63) 0.02 (0.05)
ARNTL2, aryl hydrocarbon receptor nuclear translocator-like 2; CLOCK, circadian locomotor output cycles kaput; DBP, D site of albumin
promoter (albumin D-box) binding protein; PSQI, Pittsburgh Sleep Quality Index; PER, period homologue (PER1, PER2, PER3); FBXL3,
F-box and leucine-rich repeat protein 3; GNb3, guanine nucleotide binding protein beta 3; SE, standard error.
The table presents the standardized regression coefﬁcients for linear regression analyses using additive, recessive and dominant models of
inheritance for the various sleep measures. Signiﬁcant results are highlighted in bold type.
*Nominally signiﬁcant results (P < 0.05).
**Signiﬁcant result following multiple testing correction (P < 0.005).
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(P = 0.005) (see Fig. 2a). These results indicate that the TT
individuals (n = 88) had a lower global PSQI score, and thus
less overall sleep disturbance (mean = 5.10, SD = 2.8), than
the CC and CT individuals (mean = 5.97, SD = 3.1). In the
combined analysis (including all 10 SNPs investigated), this
SNP was still nominally signiﬁcant in a recessive model
(b = 0.7, P = 0.04).
Sleep duration
There was a signiﬁcant association between the PER2 SNP
rs2304672 and sleep duration using a recessive model
(P < 0.001). These results indicate that the rare GG individ-
uals (n = 3) had a longer sleep duration (mean = 8.2 h,
SD = 0.3) than the CC and CG individuals (mean = 7.5 h,
SD = 1.2).
There was also a nominally signiﬁcant association
between the GNb3 SNP rs5443 and sleep duration using a
recessive model (P = 0.03) (see Fig. 2b). These results
indicate that the TT individuals (n = 88) had a longer sleep
duration (mean = 7.7 h, SD = 1.0) than the CC and CT
individuals (mean = 7.4 h, SD = 1.2).
In the combined analysis (including all 10 SNPs investi-
gated), the associations with both the PER2 SNP rs2304672
(b = 0.6, P < 0.001, recessive) and the GNb3 SNP rs5443
(b = 0.29, P = 0.03, recessive) remained mainly unchanged.
We additionally found a novel association with the rare FBXL3
SNP 825679097 (b = 1.3, P < 0.0001, additive model).
Sleep latency
There was a nominally signiﬁcant association between the
ARNTL2 SNP rs922270 and sleep latency in both an additive
model (P = 0.045) and a recessive model (P = 0.02) (see
Fig. 3a). These results indicate that the CC individuals
(n = 17) had a lower sleep latency, thus taking a shorter
period of time to fall asleep (mean = 20.7 min, SD = 13.3)
than the TC (mean = 26.1 min, SD = 24.3) and TT individ-
uals (mean = 28.7 min, SD = 23.2).
There was also a nominally signiﬁcant association
between the DBP SNP rs3848543 and sleep latency in both
(a)
(b)
Figure 1. Period homologue 3 (PER3) and aryl hydrocarbon
receptor nuclear translocator-like 2 (ARNTL2) single nucleotide
polymorphisms (SNPs) are associated with diurnal preference.
(a)
(b)
Figure 2. Guanine nucleotide binding protein beta 3 (GNb3) is
associated with variations in global sleep quality and sleep duration
in recessive models.
(a)
(b)
Figure 3. Aryl hydrocarbon receptor nuclear translocator-like 2
(ARNTL2) and D site of albumin promoter (albumin D-box) binding
protein (DBP) are associated with variations in sleep latency.
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an additive model (P = 0.047) and a dominant model
(P = 0.02) (see Fig. 3b). These results indicate that the CT
individuals (n = 231) had a lower sleep latency, thus taking a
shorter period of time to fall asleep (mean = 24.9 min,
SD = 18.2) than the CC (mean = 28.8 min, SD = 24.9) and
TT individuals (mean = 28.9 min, SD = 25.7). In the com-
bined analysis (including all 10 SNPs investigated), we found
only a nominal trend towards signiﬁcance for the DBP SNP
(b = 2.7, P = 0.09, additive model).
Sleep quality
There was a signiﬁcant association between the FBXL3 SNP
825679097 and sleep quality using an additive model
(P < 0.001). These results indicate that the rare GT individ-
uals (n = 2) had a lower sleep quality score, thus better sleep
quality (mean = 1.0, SD = 0.0), than the GG individuals
(mean = 1.1, SD = 0.7).
There was also a signiﬁcant association between the
PER2 SNP rs2304672 and sleep quality using a recessive
model (P < 0.001). These results indicate that the rare GG
individuals (n = 3) had a lower sleep quality score, thus
better sleep quality (mean = 1.0, SD = 0.0), than the CC and
CG individuals (mean = 1.1, SD = 0.7).
There were nominally signiﬁcant associations between the
ARNTL2 SNP rs922270 and sleep quality in both additive
(P = 0.03) and dominant models (P = 0.02) and the GNb3
SNP rs5443 and sleep quality in both additive (P = 0.03) and
recessive models (P = 0.01) (see Fig. 4a,b). The ARNTL2
CC individuals (n = 17) and the GNb3 TT individuals (n = 89)
had lower sleep quality scores, and thus better sleep quality
(mean = 1.1, SD = 0.6 and mean = 1.0, SD = 0.7), respec-
tively, than the other genotypes (see Table 2 for details).
In the combined analysis (including all 10 SNPs investi-
gated), only the rare FBXL3 SNP 825679097 was nominally
signiﬁcant (b = 0.14, P = 0.04, additive model).
DISCUSSION
Diurnal preference
We found a signiﬁcant association of a PER3 SNP
rs10462020 with diurnal preference. This ﬁnding is in line
with a wide range of studies showing that genetic variation in
the PER3 gene is associated with diurnal preference (Archer
et al., 2003; Ebisawa et al., 2001), including a study that also
found the G allele to be associated with increased morning
preference (Johansson et al., 2003). This SNP is also part of
a haplotype associated with delayed sleep phase syndrome
(Ebisawa et al., 2001). Taken together, these studies suggest
that this gene may play a role in regulating diurnal preference.
The PER3 SNP was found to be signiﬁcantly out of HWE in
the total sample, but not in the male subsample. As the
association between this SNP and diurnal preference was
signiﬁcant in both the total sample and the male subsample,
this suggests that this association is unlikely to be due to
genotyping error. Failure to reach HWE could be due to a
number of other factors, including non-random mating, which
occurs with morningness–eveningness (Randler and Kretz,
2011).
The mechanism by which the PER3 gene modulates
diurnal preference is uncertain, as diurnal preference can be
affected by both circadian rhythms and sleep homeostasis.
Period genes act as negative regulators of the molecular
clock, with Per1 and Per2 playing more central roles than
Per3. Per1 and Per2 knockout mice have a shorter circadian
period, while the Per3 knockout mice have only subtle (Bae
et al., 2001) or no differences in circadian period (Van der
Veen and Archer, 2010). Additionally, while Per1/Per2 double
knockout mice are arrhythmic in constant darkness, Per1/
Per3 or Per2/Per3 double knockout mice are not (Bae et al.,
2001). More recently, the PER3 gene has also been shown to
play a role in sleep homeostasis in humans (Viola et al.,
2007) and its orthologue plays the same role in mice (Hasan
et al., 2011). It is not known whether this missense SNP is
functional, but as this residue is conserved across most
period homologues and is proximal to predicted Csnk1e
target sites, it may directly underlie this association (Ebisawa
et al., 2001).
We also found a nominally signiﬁcant association between
an ARNTL2 SNP rs922270 and diurnal preference. This is
the ﬁrst time a SNP in the ARNTL2 gene has been
associated with diurnal preference. The C allele for this
SNP had previously been associated with better afternoon/
evening mood in a bipolar sample (Shi et al., 2008). As better
afternoon and evening moods are associated with morning
and evening preferences, respectively (Kerkhof, 1998), it is
(a)
(b)
Figure 4. Aryl hydrocarbon receptor nuclear translocator-like 2
(ARNTL2) and guanine nucleotide binding protein beta 3 (GNb3)
are associated with variations in sleep quality.
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difﬁcult to relate these ﬁndings to our own. ARNTL2 was
thought to be unnecessary for the core circadian clock, as its
paralogue Arntl is the only circadian gene that when knocked
out on its own causes arrhythmic locomotor activity in mice
(Bunger et al., 2000). Recently, it has been found that Arntl
knockout mice have decreased Arntl2 mRNA expression and
that the arrhythmic locomotor activity can be rescued by
Arntl2 if it is driven by a constitutively activated promoter (Shi
et al., 2010). The ARNTL2 protein may play an important role
in the molecular clock, and thus genetic variation in ARNTL2
could directly impact diurnal preference by affecting the core
molecular clock. As this SNP is intronic, and not known to
affect splicing, it is possible that it is in linkage disequilibrium
with another functional SNP that, in turn, may underlie this
association.
The associations with PER3 and ARNTL2 were still
signiﬁcant in the combined analysis including all 10 SNPs,
suggesting that they are at least partially independent. This
analysis also found associations of SNPs in FBXL3 and
GNb3, with diurnal preference not revealed in the individual
analyses. For the GNb3 association the T allele was
associated with increased morningness, which matches a
previous study (Johansson et al., 2004), while this is the ﬁrst
association of a FBXL3 SNP with diurnal preference in
humans, although Fbxl3 mutant mice are known to have an
altered circadian period (Godinho et al., 2007).
Global PSQI score
We found a novel signiﬁcant association between the func-
tional GNb3 SNP rs5443 and the global PSQI sleep quality
score. This SNP is part of a haplotype that was associated
previously with diurnal preference (Lee et al., 2007). Addi-
tionally, two other SNPs in this gene have been associated
with increased wakefulness after sleep onset in an elderly
population (Evans et al., 2013). Although this SNP does not
cause an amino acid change, it has been shown to lead to
alternative splicing, leading in turn to the shorter Gnb3-s
isoform which causes increased signal transduction (Siffert
et al., 1998). This gene codes for the beta-subunit of the
membrane-associated heterotrimeric guanine nucleotide
binding proteins (G-proteins). G-proteins are integral to a
number of secondary messenger pathways, including those
for serotonin and noradrenaline receptors (Millan et al., 2008),
both of which are involved in sleep mechanisms (Murillo-
Rodriguez et al., 2012). It is thus possible that this SNP
directly underlies these associations by altering the signalling
pathways of one of these key neurotransporter systems.
Sleep duration
Both the PER2 SNP rs2304672 and the GNb3 SNP rs5443
were associated with sleep duration. Genetic variation in
PER2 has been associated previously with advanced sleep
phase syndrome (ASPS) (Toh et al., 2001); additionally, Per2
knockout mice have initially diminished delta activity in
response to sleep deprivation (Kopp et al., 2002). Of the
two large genome-wide association studies (GWAS) con-
ducted for sleep measures, one found a nominally signiﬁcant
association of genetic variation in PER2 with sleep duration
(Allebrandt et al., 2013), while the other found that genetic
variation in PER3 was nominally associated with sleep
duration and sleep latency (Byrne et al., 2013). Part of the
discrepancy between these studies and our ﬁndings may be
due to the fact that different questionnaires were used to
measure subjective sleep characteristics. The PER2 associ-
ation is due to a rare genotype and thus may be due to
chance, although it is worth noting that rare SNPs are thought
to explain a portion of the heritability that is missing from
GWAS studies (Dickson et al., 2010; Manolio et al., 2009).
Both these associations remained mainly unchanged in a
combined analysis of these two SNPs, suggesting that two
associations are independent of each other. This analysis
also found an association between the FBXL3 SNP with
sleep duration not revealed in the individual analyses, which
is the ﬁrst reported association of FBXL3 with sleep duration.
Sleep latency
We found nominally signiﬁcant associations of both ARNTL2
and DBP with sleep latency. The effects of ARNTL2 may be
related to its potential role in regulating sleep timing
discussed above. The DBP SNP was associated previously
with worse evening mood (Shi et al., 2008). Interestingly,
there is a wealth of evidence that Dbp gene expression
decreases following sleep deprivation in both mice and rats
(Curie et al., 2013; Franken et al., 2007; Wisor et al., 2002).
These ﬁndings suggest that DBP may directly play a role in
sleep homeostasis.
In the combined analysis, the DBP association remained,
while the ARNTL2 association disappeared. This suggests
that the ARNTL2 association is not independent of the DBP
association.
Sleep quality
Four SNPs were associated with sleep quality, two of which
were very rare: FBLX3 (n = 2) and PER2 (n = 3). This is the
ﬁrst study suggesting that FBXL3 may play a role in the
regulation of sleep. Animal models with mutations in Fbxl3
have a longer circadian period (Godinho et al., 2007), but no
study has investigated this gene’s role in sleep homeostasis.
In the combined analysis only the FBLX3 association was
signiﬁcant.
Candidate gene association studies
Genome-wide association studies approaches demonstrate
that there are likely to be a large number of genes that affect
sleep measures, most of which have small effects. Candidate
gene approaches can be useful in determining genetic
variants with small effects as they do not require the same
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scale of multiple testing corrections required in GWAS
approaches, but they have limitations (Lewis and Knight,
2012). Any candidate gene approach requires that the a priori
rationale for its selection is valid. Additionally, as with GWAS
studies, it is difﬁcult to determine the causal variant under-
lying the association and signiﬁcant associations may be
false positives. Finally, any candidate gene association study
needs to be replicated in additional and varied samples
(Lewis and Knight, 2012).
In summary, we found that genetic variation in genes with
circadianexpression is associatedwith both diurnal preference
(PER3 and ARNTL2) and speciﬁc subjective sleep measures
(GNb3). These ﬁndings are in line with previous studies that
found circadian gene involvement in sleep homeostasis
(Franken, 2013; Franken and Dijk, 2009; Wisor et al., 2002),
andstress the importanceof further studiesaimedat dissecting
the speciﬁc roles that individual circadian genes play in these
two interrelated but distinct behaviours. Further studies com-
bining new technologies, such as next-generation sequencing
that allows for detectionofall SNPs, and theuseofmore reﬁned
phenotypic measurements, such as employing actigraphy or
polysomnography,will be critical in dissecting the speciﬁc roles
of circadian genes in these behaviours.
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